CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...